Uremic Encephalopathy Treatment & Management
- Author: James W Lohr, MD; Chief Editor: Vecihi Batuman, MD, FACP, FASN more...
No medications are specific to the treatment of encephalopathy.
- The presence of uremic encephalopathy in a patient with either acute kidney injury or chronic kidney failure is an indication for the initiation of dialytic therapy (ie, hemodialysis, peritoneal dialysis, continuous renal replacement therapy). After beginning dialysis, the patient generally improves clinically, although EEG findings may not improve immediately.
- In patients with end-stage renal disease (ESRD), EEG abnormalities generally improve after several months but may not completely normalize.
- Address the following factors when treating uremic encephalopathy, which are also included in the standard care of any patient with ESRD:
- Adequacy of dialysis
- Correction of anemia
- Regulation of calcium and phosphate metabolism
See the list below:
- Consult a neurologist if symptoms do not improve upon initiation of dialysis therapy.
- Consult a vascular surgeon for placement of vascular access in patients with ESRD.
- Refer patients with ESRD to a dietitian familiar with renal diseases.
See the list below:
- To avoid malnutrition in patients with ESRD, maintain adequate protein intake (1.2 g/kg/d) and initiate dialysis (despite the presence of encephalopathy).
Instruct patients with significant symptoms to continue bed rest.
Bolton CF, Young GB. Encephalopathy of chronic renal failure. Neurological Complications of Renal Disease. 1990. 49-74.
Brouns R, De Deyn PP. Neurological complications in renal failure: a review. Clin Neurol Neurosurg. 2004 Dec. 107(1):1-16. [Medline].
Arieff AI. Nervous system manifestations of renal failure. Schrier RW, ed. Diseases of the Kidney. Lippincott; 2007. 2460-2482.
Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol. 2011 Apr. 31(2):139-43. [Medline].
Biasioli S, D'Andrea G, Feriani M, Chiaramonte S, Fabris A, Ronco C, et al. Uremic encephalopathy: an updating. Clin Nephrol. 1986 Feb. 25(2):57-63. [Medline].
Biasioli S. Neurologic aspects of dialysis. Nissenson A, Fine R, eds. Clinical Dialysis. 2005. 855-876.
Moe SM, Sprague SM. Uremic encephalopathy. Clin Nephrol. 1994 Oct. 42(4):251-6. [Medline].
Deguchi T, Isozaki K, Yousuke K, Terasaki T, Otagiri M. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier. J Neurochem. 2006 Feb. 96(4):1051-9. [Medline].
De Deyn PP, Vanholder R, Eloot S, et al. Guanidino compounds as uremic (neuro)toxins. Semin Dial. 2009 Jul-Aug. 22(4):340-5. [Medline].
Liu M, Liang Y, Chigurupati S, Lathia JD, Pletnikov M, Sun Z, et al. Acute kidney injury leads to inflammation and functional changes in the brain. J Am Soc Nephrol. 2008 Jul. 19(7):1360-70. [Medline].
Nomoto K, Scurlock C, Bronster D. Dexmedetomidine controls twitch-convulsive syndrome in the course of uremic encephalopathy. J Clin Anesth. 2011 Dec. 23(8):646-8. [Medline].
Yamamoto T, Satomura K, Okada S, et al. Risk factors for neurological complications in complete hemolytic uremic syndrome caused by Escherichia coli O157. Pediatr Int. 2009 Apr. 51(2):216-9. [Medline].
Schmidt M, Sitter T, Lederer SR, Held E, Schiffl H. Reversible MRI changes in a patient with uremic encephalopathy. J Nephrol. 2001 Sep-Oct. 14(5):424-7. [Medline].